how is hims still selling compounded semaglutide & Hers Health will stop compound GLP-1 to settle lawsuit Readout Newsletter: Makary hearing, Hims,

For someone with eating disorder vulnerability, these unknowns carry significant risk

This is significantly higher than what most current treatments achieve, making retatrutide a potential game-changer for people struggling with obesity

Weight loss outcomes vary by agent and dose: high-dose semaglutide (2.4mg/Wegovy) has shown mean weight reductions of approximately 15% in the STEP clinical trials, while liraglutide (3mg/Saxenda) typically achieves 5-8% weight loss

Why it matters: Peptide medications like semaglutide and tirzepatide can degrade over time, particularly if stored improperly

The risks have come into sharp focus during the present pandemic

Akyol-Salman I, Azizi S, Mumcu U, Baykal O